Delivery Order SPE2DB22D3501-SPE2DB25FWS45
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Proparacaine 0.5% eye drops in 15ml quantities. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,097.76 with an ultimate completion date of September 18, 2025. The contract was awarded on September 17, 2025, and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award carries...
- The Defense Logistics Agency awarded a $1,181.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Proparacaine 0.5% eye drops (15 mL) on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Proparacaine 0.5% eye drops in 15ml quantities. This order, valued at $1,458.94, represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Proparacaine 0.5% Eye Drops in 15ml quantities, with a ceiling value of $1,097.76. This firm fixed-price delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Proparacaine 0.5% Eye Drops (15ml) with a ceiling value of $1,332.21. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was competitively awarded....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,506.12 by the Defense Logistics Agency on August 22, 2025, for the supply of Proparacaine 0.5% eye drops in 15ml quantities. The contract is firm fixed price with an ultimate completion date of August 25, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Proparacaine 0.5% eye drops. The contract has a ceiling value of $2,959.98 and a performance period ending on July 1, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,019.16 Firm Fixed Price Delivery Order is for the supply of 4564339906 - Proparacaine 0.5% Eye Drops, 15ML. This contract has no set-aside designation and is for the ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Proparacaine 0.5% eye drops. The order has a ceiling value of $1,061.28 and is a firm fixed price contract with a completion date of July 3, 2024. The contract does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,061.28 firm fixed-price delivery order is for the supply of 0.5% Proparacaine Eye Drops with a completion date of October 23, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWS45Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,481.14 to AmerisourceBergen Drug Corp for the supply of Proparacaine 0.5% eye drops in 15ml quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 5, 2025. The award was issued on August 4, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has demonstrated substantial capability in fulfilling federal medical supply requirements through competitive procurement. The company serves as a critical vendor for the DLA Medical Supply Chain, supplying a broad portfolio of pharmaceutical products and medical commodities to support military healthcare systems and the Defense Health Agency. This specific delivery order for ophthalmic pharmaceutical products represents one of numerous routine procurement transactions under the parent IDC vehicle, which enables flexible and efficient sourcing of medications and medical supplies across multiple therapeutic domains for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/4/25 |